TS8B: YOUR NGS LAB: RELEVANT ISSUES FROM TEST DEVELOPMENT TO COMMERCIALIZATION

WEDNESDAY, AUGUST 21 AND THURSDAY, AUGUST 22
DAY 1: 2:05 - 6:30 PM | DAY 2: 8:30 AM - 4:20 PM

Arlington

INSTRUCTORS:

Jamie Platt, PhD, CEO, Founder, BRIDGenomics, LLC

Shawn Clairmont, MBA, COO, Co-Founder, BRIDGenomics, LLC

Robert Young, CGMBS, MS Bioinformatics, Owner, Principal Consultant, Lab Insights, LLC

Naomi Thomson, Vice President, Clinical Genomics, BRIDGenomics, LLC

Eden Hutchinson, BRIDGenomics, LLC

Nearly 10 years after the first publication of next-generation sequencing, this paradigm shifting technology has progressively migrated into the clinical diagnostic space. A diversity of clinical diagnostic assays is now routinely performed on a variety of NGS platforms, spanning from single gene to multi-gene sequencing, to genome wide analyses for the detection of germline and somatic mutations. For clinical laboratories with NGS experience, and especially for those just starting to use the technology, designing and operationalizing robust NGS assays remains a challenge. This training seminar will review principles and diagnostic approaches for NGS assays as applied to molecular oncology and inherited disorders, platforms and instruments, as well as laboratory accreditation and proficiency testing specific to NGS.

INSTRUCTOR BIOGRAPHY:

Jamie Platt, PhD, CEO, Founder, BRIDGenomics, LLC

Jamie Platt has 15 years of leadership in NGS and Clinical Diagnostics. She has worked on the assay development & commercialization of more than 22 NGS & 35 high-complexity molecular LDTs. She propelled and directed a global $4.7B Fortune 500 diagnostics provider into the emerging genomics market through adoption of NGS technology (2005). She spearheaded development & validation of the first NGS-based HIV test for large commercial reference lab (secured NYS approval) and increased revenue by $1M within 6 months of launch. And has a strong track record of building NGS-based Genomics programs with FDA-aligned, design control development QMS and ISO 15189 readiness for growth from clinical into Pharma services markets.

Training Seminar Information

Each Training Seminar offers 1.5 Days of instruction with start and stop times for each day shown above and on the Event-at-a-Glance published in the onsite Program & Event Guide. Training Seminars will include morning and afternoon refreshment breaks, as applicable, and lunch will be provided to all registered attendees on the full day of the class.

Each person registered specifically for the training seminar will be provided with a hard copy handbook for the seminar in which they are registered. A limited number of additional handbooks will be available for other delegates who wish to attend the seminar, but after these have been distributed no additional books will be available.

Though CHI encourages track and symposia hopping between conference programs, we ask that Training Seminars not be disturbed once they have begun. In the interest of maintaining the highest quality learning environment for Training Seminar attendees, and because Seminars are conducted differently than conference programming, we ask that attendees commit to attending the entire program, and NOT engaging in track hopping, as to not disturb the hands-on style instruction being offered to the other participants.